Back
Speaker illustration

Doctor Xiaopei Cui

Shandong University Qilu Hospital, Jinan (China)

Member of:

European Society of Cardiology

Presentations

Efficacy and safety of selexipag based triple combination targeted drug therapy in chinese patients with pulmonary arterial hypertension

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Pulmonary arterial hypertension therapy

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources